CI — Cell Impact AB (publ) Cashflow Statement
0.000.00%
- SEK58.92m
- SEK69.45m
- SEK37.33m
Annual cashflow statement for Cell Impact AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | C2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -43.1 | -78 | -103 | -119 | -99 |
Depreciation | |||||
Non-Cash Items | 0.074 | 10 | 16.4 | 5.06 | 19.5 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -11.3 | -18 | -18.9 | -11.6 | -9.04 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -47.6 | -86.1 | -106 | -106 | -62.2 |
Capital Expenditures | -22 | -54.3 | -68.4 | -53.5 | -14.4 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.08 | -0.012 | -0.004 | 0 | -0.001 |
Sale of Fixed Assets | |||||
Purchase of Investments | |||||
Change in Net Intangibles | |||||
Cash from Investing Activities | -22 | -54.3 | -68.4 | -53.5 | -14.4 |
Financing Cash Flow Items | -12.3 | 0.586 | -45.3 | -21.9 | -8.18 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 205 | 17 | 310 | 94.6 | -2.84 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 135 | -123 | 136 | -64.8 | -79.5 |